UTRN and Duchenne muscular dystrophy: Subsequently, a micro-utrophin packaged into a recombinant AAV6 vector was intravenously delivered in 1 month-old mdx/Utr+/− mice, which have a more severe phenotype compared to mdx mice, thus mimicking human DMD patients (104).